Abbott Laboratories to Pay $385 Million Settlement Over 2022 Formula Plant Closure
Abbott Laboratories has agreed to a $385 million settlement to resolve a Justice Department investigation and lawsuit. The legal action followed the 2022 closure of the company's Michigan manufacturing facility, which triggered a nationwide baby formula shortage.
Abbott Laboratories announced it will pay $385 million to settle legal claims stemming from a federal investigation into its manufacturing practices. The settlement addresses a lawsuit brought by the U.S. Department of Justice regarding the company's handling of safety protocols and the subsequent 2022 recall of powdered infant formula produced at its Sturgis, Michigan, plant.
The closure of the Sturgis facility, which was the largest baby formula plant in the United States, significantly disrupted the national supply chain. The resulting shortage forced many families to struggle to find essential nutrition for their infants, leading to government intervention and increased scrutiny of the formula industry's safety standards. While the settlement resolves the specific claims brought by the Justice Department, it marks a significant financial conclusion to the regulatory fallout that followed the contamination concerns identified at the site. The company has not issued a statement admitting to specific wrongdoing as part of the settlement agreement, focusing instead on the resolution of the litigation.
📡 Media Analysis
How each outlet framed the story — angles, word choices, and what they chose to push or ignore.
Focused on the financial penalty and the direct link to the 2022 supply crisis.
"resolve claims tied to an investigation"
🔍 What Nobody's Reporting
- ·Lack of detail regarding the specific safety violations that led to the initial closure.
- ·No mention of the current status of the Michigan plant's operations or safety improvements.
📰 Sources
0 A-rated source(s) among 1 total. Lowest trust: The Independent (B)